![]() |
市场调查报告书
商品编码
1847171
全球空心螺丝市场:市场规模、份额和趋势分析(2025-2031 年)Cannulated Screw Market Size, Share, & Trends Analysis | Global | 2025-2031 | Includes: Stainless Steel Screws, and 1 more |
||||||
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
2024年全球空心螺丝市场规模为5.99亿美元。预计到2031年,该市场规模将达到6.93亿美元,年复合成长率为2.1%。
本报告涵盖了所有带孔螺丝产品,并按材质和尺寸等级进行了分类。报告涵盖了不銹钢和钛合金螺丝,并对小型、中型和大型螺丝进行了单位分析。研究量化了销售量、平均售价 (ASP)、市场规模、成长率和企业市场占有率。此外,报告还分析了市场驱动因素和限制因素、手术趋势、近期併购以及技术趋势。报告提供截至 2021 年的历史数据,并预测至 2031 年。
市场概览
空心螺丝是整形外科创伤固定术的核心组成部分。其中空设计使其能够沿着导管导引线插入,从而在多种适应症中提高操作性、对位性和精准度。外科医生依靠空心螺丝来稳定骨折、进行截骨术以及辅助上下肢的固定手术。由于使用这些植入的手术通常至关重要且紧急,因此其需求在经济週期中保持稳定。
创伤护理领域手术量的稳定性以及踝足手术、手腕手术和关节周围融合术等广泛领域的应用,持续推动市场的发展。然而,许多竞标和联合采购协议中也出现了价格压力。这些因素导致仿製药的平均售价呈下降趋势,而具有增值设计特性的产品,例如提高舒适度、减少软组织刺激以及透过加压促进癒合等,则可以维持价格。
材料的选择会影响采购和临床应用。钛合金因其优异的生物相容性和轻质特性而不断扩大市场份额。在许多地区,钛合金和不銹钢的价格差异正在缩小,这促使临床医生在处理小到中等骨折碎片时选择钛合金。不銹钢在需要高刚度的领域中仍然发挥着重要作用,尤其是在大骨折碎片固定术和高负荷手术中。
产品研发主要集中在两个方面。首先,在材料科学领域,正在研发新型钛合金,以提高强度、耐久性和螺纹完整性,尤其是在髋关节和关节周围区域。其次,在螺丝头部设计方面,无头空心螺丝的应用日益广泛,这种螺丝能够更好地黏附在骨表面,减少对软组织的刺激。无头设计的这种趋势推高了该细分市场的平均售价(ASP),有助于缓解传统带头螺丝产品的价格压力。
各地区市场表现将有所不同。成熟市场由于采购集中化,倾向于大量采购标准尺寸产品,并优先考虑供应可靠性和服务响应速度。新兴市场随着创伤护理服务的改善,销售量将有所成长,但公开竞标定价可能面临挑战。总体而言,对必要手术的需求、钛合金使用量的增加以及无头设计产品的成长预计将共同推动整个预测期内保持个位数低成长。
市场驱动因素
钛的生长
钛合金空心螺丝因其显着的临床优势,且与不銹钢螺丝相比价格差异相对较小,市场份额持续成长。钛合金的生物相容性和轻质特性可提高患者舒适度并降低不良反应的风险。这些特性在用于手、腕、足部等部位的小直径和中直径螺钉中尤其重要,因为这些部位的软组织相容性和长期相容性至关重要。
同时,供应商正投资研发新型钛合金,旨在提升疲劳性能和螺纹耐久性。这些进步对于股骨颈固定和多碎片关节周围骨折等复杂适应症尤其重要。随着更多合金材料的上市,临床医师将能根据负荷、骨质和癒合目标等因素,更灵活地选择合适的材料。对钛合金的持续关注,有助于维持该品类平均售价的稳定,并推动其价值成长。
无头螺丝的成长
无头空心螺丝是成长迅速的细分市场。消除突出螺丝头的设计降低了软组织刺激和植入引起症状的风险,从而减少了二次取出的需要。许多无头系统采用双螺纹或可调螺距结构,从两端产生压缩力。这项特性有助于在适当的早期活动和负重阶段保持骨折碎片的对合和骨折碎片间的稳定性。
无头螺钉的平均售价高于有头螺钉,并且在包括舟骨、跖骨和趾骨骨折以及某些踝关节和距下关节融合术在内的多个解剖部位均呈现较高的销量增长率。随着外科医生致力于最大限度地减少患者的不适感和再次手术率,预计在整个预测期内,对无头螺丝产品的需求将持续增长。
在急诊手术中的作用
空心螺丝用于紧急手术,这些手术一旦进行就存在风险,必须立即进行。急诊和创伤中心依靠它们快速固定髋关节、踝关节、腕关节和足部损伤。由于这些手术至关重要,其需求比择期手术更为稳定。这种稳定性也意味着,与非紧急医疗器材市场相比,空心螺丝的价格往往更为坚挺,因为在非紧急医疗设备市场,竞争性竞标会影响合约结果。
市场限制
平均售价(ASP)下降
儘管市场需求强劲,但空心螺丝的平均售价仍面临来自集团采购组织、政府竞标和基于价值的采购计划的持续压力。这些机制集中了采购力量,并加剧了价格竞争。在北美、西欧和中国等地区,价格持续受到压缩,其中中国在2021年底实施政策调整后价格显着下降。在预测期内,这些采购模式将继续限制价格成长,并抑制传统产品线的价值成长。
螺丝商品化
儘管无头螺丝设计正逐渐获得创新动力,但许多带头空心螺丝却趋于同质化。产品差异化程度有限,标准带头螺丝产品线很少增加新功能。当产品被认为可以互换时,竞标受单位成本和物流成本驱动。因此,带头螺丝的平均售价预计不会大幅上涨,该细分市场的成长将主要依赖销量,而非价值。
足科医生平均售价下降
踝关节手术领域的平均售价通常低于整形外科创伤领域。这反映了足病学领域中独特的病例组合、采购模式和竞争环境。鑑于踝关节融合手术中空心螺丝的普遍使用,该管道较低的价格拉低了整体市场价值。虽然中空通常会提供捆绑销售和标准套装以提高效率,但平均售价的结构性差异预计仍将持续存在。
竞争分析
德普合成公司
2024年,DePuy Synthes继续保持在空心螺丝市场的领先地位。该公司用途广泛的空心螺丝产品线涵盖小、中、大等多种尺寸。其主导地位得益于其全球规模、在创伤领域的深厚人脉以及为医院和门诊机构提供的可靠供应。凭藉其广泛的分销网络和与外科医生偏好的契合度,预计DePuy Synthes将在整个预测期内保持其领先地位。
史赛克
史赛克在全球市占率排名第二。该公司旗下的中空螺丝品牌包括Asnis III、AutoFix、Asnis Micro、TwinFix、Mini和Fixos。这些产品满足不同的解剖结构需求,并具有简化的器械操作和易于上手的特性。史赛克的策略是将螺丝产品线与更广泛的创伤平台结合,以扩大基本客群。预计该公司将在保持市场份额的同时,充分利用相邻且成长更快的创伤领域的成长潜力。
Zimmer Biomet
捷迈邦美凭藉其MAX VPC™螺丝系统和N-Force固定係统®保持了第三的位置。该公司在关键地区的市占率保持稳定,并期望在竞争对手专注于其他高成长领域的市场扩大份额。均衡的定价和可靠的分销网络为其在医院竞标和民营市场的持续参与提供了支持。
其他跨国公司和区域供应商则在特定地区或适应症领域竞争。这些公司通常专注于服务应对力、区域物流以及针对踝关节、足部或手部手术的特定产品线。虽然它们可能不会显着改变全球市场份额,但它们加剧了区域竞标中的价格竞争,并对同质化产品类别的平均售价(ASP)构成压力。
市场和数据覆盖范围
单元分析按小型、中型和大型螺丝类别进行细分,并按地区对应到材料选择。
科技与临床趋势
包括调查方法附录和简称表。
图表清单
图表列表
调查方法
全球关税的影响
空心螺丝市场
The global cannulated screw market was valued at $599 million in 2024. The market is projected to grow at a compound annual growth rate (CAGR) of 2.1%, reaching $693 million by 2031.
This report covers the full suite of cannulated screw products by material and size class. Scope includes stainless steel and titanium screws, with unit analysis across small, medium, and large screw categories. The study quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and examines market drivers and limiters, procedure dynamics, recent mergers and acquisitions, and technology trends. Historical data are provided to 2021, with forecasts through 2031.
Market Overview
Cannulated screws are a core element of orthopedic trauma fixation. Their hollow design allows placement over a guidewire, which improves control, alignment, and accuracy across a wide range of indications. Surgeons rely on cannulated screws to stabilize fractures, manage osteotomies, and support fusions in both upper and lower extremities. Because the procedures that use these implants are essential and often urgent, demand remains consistent across economic cycles.
The market continues to benefit from steady procedural volume in trauma care and from broader use in foot and ankle surgery, hand and wrist surgery, and periarticular fixation. At the same time, pricing pressure is present in many tenders and group purchasing agreements. These forces pull ASPs down for commoditized items, but value can be sustained where design features improve comfort, reduce soft tissue irritation, or enable compression that supports healing.
Material choice shapes purchasing and clinical use. Titanium has gained share due to favorable biocompatibility and lighter weight. The price gap between titanium and stainless steel is narrow in many regions, which encourages clinicians to select titanium for small and medium fragment cases. Stainless steel maintains a strong role where higher stiffness is desirable, especially in large fragment constructs and high-load indications.
Product development focuses on two areas. The first is material science, with suppliers exploring new titanium alloys that target strength, durability, and thread integrity, especially in hip and periarticular applications. The second is head design, where headless cannulated screws continue to gain use because they sit flush with bone and reduce soft tissue irritation. The trend toward headless designs supports higher ASPs within that subsegment and helps offset pricing pressure in traditional headed lines.
Regional performance varies. Mature markets with centralized procurement favor high-volume standard sizes and reward supply reliability and service response. Emerging markets expand units as access to trauma care improves, though pricing in public tenders may be tight. Overall, the balance of essential procedure demand, rising use of titanium, and growth in headless designs supports low single-digit value growth through the forecast period.
Market Drivers
Growth of Titanium
Titanium cannulated screws continue to expand share because the price difference versus stainless steel is often modest, while the clinical advantages are clear. Titanium's biocompatibility and lower weight can improve patient comfort and reduce the chance of adverse reactions. These characteristics are most valued in small and medium screws used in the hand, wrist, and foot, where soft tissue tolerance and long-term compatibility matter.
In parallel, suppliers are investing in new titanium alloys aimed at better fatigue performance and thread durability. These advances are particularly relevant for challenging indications such as femoral neck fixation or multi-fragment periarticular fractures. As more alloy options reach the market, clinicians will have greater ability to tailor material to load, bone quality, and healing goals. This sustained focus on titanium supports a stable ASP mix and incremental value growth in the category.
Growth of Headless Screws
Headless cannulated screws are a fast-growing subsegment. By eliminating a prominent screw head, these designs reduce soft tissue irritation and the risk of symptomatic hardware, which lowers the need for secondary removal. Many headless systems use dual-threaded or variable pitch constructs to generate compression from both ends. This feature helps draw fragments together and maintain interfragmentary stability during early motion and weight bearing where appropriate.
Headless screws carry higher ASPs than headed screws and demonstrate higher unit growth rates in several anatomical areas, including scaphoid, metatarsal, and phalangeal fractures, as well as selected ankle and subtalar fusions. As surgeons aim to minimize patient discomfort and reoperation rates, demand for headless options is expected to continue rising across the forecast period.
Role in Essential Surgery
Cannulated screws are used in non-elective procedures that cannot be deferred without risk. Emergency departments and trauma services rely on them for rapid fixation of hip, ankle, wrist, and foot injuries. Because these procedures are essential, unit demand is more stable than in categories tied to elective care. This stability also means pricing tends to be more resilient than in non-urgent device markets, although tender competition still influences contract outcomes.
Market Limiters
ASP Decreases
Despite healthy procedural demand, cannulated screw ASPs face steady pressure from group purchasing organizations, government tenders, and value-based procurement programs. These mechanisms concentrate purchasing power and focus competition on price. Regions such as North America, Western Europe, and China have seen persistent price compression, with China experiencing strong declines following policy changes introduced at the end of 2021. Over the forecast period, these procurement models will continue to limit pricing upside and hold back value growth in conventional lines.
Commoditization of Headed Screws
As headless designs capture the innovation spotlight, many headed cannulated screws have become commoditized. Product differentiation is limited, and few new features are expected for standard headed lines. When products are viewed as interchangeable, tenders emphasize unit price and logistics. As a result, headed screw ASPs are not expected to rise meaningfully, and market growth in that segment will be driven mainly by units rather than value.
Lower ASPs to Podiatrists
ASPs in foot and ankle surgery are generally lower than in trauma orthopedics. This reflects case mix, purchasing patterns, and competitive dynamics specific to podiatry. Because cannulated screws have significant use in foot and ankle fixation, the lower realized prices in that channel can weigh on overall market value. Vendors often respond through bundles and standard sets that increase efficiency, but the structural ASP gap is likely to persist.
Competitive Analysis
DePuy Synthes
DePuy Synthes held the leading share of the cannulated screw market in 2024. The company markets a broad portfolio under a generic Cannulated Screws line with multiple sizes across small, medium, and large classes. Leadership reflects global scale, deep relationships in trauma, and consistent supply across hospitals and ambulatory sites. Given its reach and alignment with surgeon preferences, DePuy Synthes is expected to maintain the top position through the forecast period.
Stryker
Stryker ranked second globally. Its cannulated screw brands include Asnis III, AutoFix, Asnis Micro, Twin Fix, MiNi, and Fixos. The range covers diverse anatomical needs and favors streamlined instrumentation and familiar handling. Stryker's strategy pairs screw portfolios with broader trauma platforms, which supports account penetration. The company is expected to hold share while leveraging growth from adjacent, faster-growing trauma segments.
Zimmer Biomet
Zimmer Biomet held the third position with the MAX VPC(TM) Screw System and N-Force Fixation System(R). The company's presence is steady in key regions, and share may expand in areas where competitors emphasize other higher-growth categories. Zimmer Biomet's balanced pricing and reliable distribution support ongoing participation in both hospital tenders and private markets.
Other multinational and regional suppliers compete in selected geographies and indications. These firms often focus on service responsiveness, regional logistics, and targeted product sets for foot and ankle or hand surgery. While they may not shift global shares dramatically, they contribute to price competition in local tenders and keep ASP pressure present in commoditized classes.
Market Coverage and Data Scope
Unit analysis is broken out by small, medium, and large screw classes and mapped to material choices by region.
Technology and Practice Trends
Methodology Appendix and Acronym Glossary included.
Where are the largest and fastest-growing opportunities within cannulated screws by material and size class through 2031.
How the shift to titanium and the rise of headless designs will influence ASPs, product mix, and purchasing decisions.
Which competitors are best positioned to defend or gain share in tenders and how portfolios compare on breadth, handling, and service.
How GPOs, government tendering, and value-based procurement programs affect pricing power across regions.
What design choices most reduce symptomatic hardware and reoperation risk in foot, ankle, hand, and wrist indications.
How vendors can use bundles, standardized sets, and service agreements to balance pricing pressure while sustaining value.
The Global Cannulated Screw Market Report from iData Research answers these questions with device-level sizing, company share analysis, and pricing detail.
Use it to quantify demand, prioritize product development, shape pricing strategy, and plan commercial execution across material and size segments.
Table Of Contents
List Of Figures
List Of Charts
Research Methodology
Impact Of Global Tariffs
Cannulated Screw Market